106 related articles for article (PubMed ID: 21830211)
1. NK cells can generate from precursors in the adult human liver.
Moroso V; Famili F; Papazian N; Cupedo T; van der Laan LJ; Kazemier G; Metselaar HJ; Kwekkeboom J
Eur J Immunol; 2011 Nov; 41(11):3340-50. PubMed ID: 21830211
[TBL] [Abstract][Full Text] [Related]
2. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells.
Jaleco AC; Blom B; Res P; Weijer K; Lanier LL; Phillips JH; Spits H
J Immunol; 1997 Jul; 159(2):694-702. PubMed ID: 9218584
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: Thymic NK cells develop independently from T cell precursors.
Ribeiro VS; Hasan M; Wilson A; Boucontet L; Pereira P; Lesjean-Pottier S; Satoh-Takayama N; Di Santo JP; Vosshenrich CA
J Immunol; 2010 Nov; 185(9):4993-7. PubMed ID: 20889548
[TBL] [Abstract][Full Text] [Related]
4. Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15.
Haraguchi K; Suzuki T; Koyama N; Kumano K; Nakahara F; Matsumoto A; Yokoyama Y; Sakata-Yanagimoto M; Masuda S; Takahashi T; Kamijo A; Takahashi K; Takanashi M; Okuyama Y; Yasutomo K; Sakano S; Yagita H; Kurokawa M; Ogawa S; Chiba S
J Immunol; 2009 May; 182(10):6168-78. PubMed ID: 19414770
[TBL] [Abstract][Full Text] [Related]
5. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.
Freud AG; Becknell B; Roychowdhury S; Mao HC; Ferketich AK; Nuovo GJ; Hughes TL; Marburger TB; Sung J; Baiocchi RA; Guimond M; Caligiuri MA
Immunity; 2005 Mar; 22(3):295-304. PubMed ID: 15780987
[TBL] [Abstract][Full Text] [Related]
6. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
Long H; Gaffney P; Mortari F; Miller JS
Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
8. Characterization of developmental pathway of natural killer cells from embryonic stem cells in vitro.
Tabatabaei-Zavareh N; Vlasova A; Greenwood CP; Takei F
PLoS One; 2007 Feb; 2(2):e232. PubMed ID: 17311098
[TBL] [Abstract][Full Text] [Related]
9. Development of human NK cells from the immature cell precursors.
Poggi A; Mingari MC
Semin Immunol; 1995 Apr; 7(2):61-6. PubMed ID: 7579195
[TBL] [Abstract][Full Text] [Related]
10. Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation.
Moroso V; Metselaar HJ; Mancham S; Tilanus HW; Eissens D; van der Meer A; van der Laan LJ; Kuipers EJ; Joosten I; Kwekkeboom J
Liver Transpl; 2010 Jul; 16(7):895-908. PubMed ID: 20583081
[TBL] [Abstract][Full Text] [Related]
11. In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split.
Plum J; De Smedt M; Verhasselt B; Offner F; Kerre T; Vanhecke D; Leclercq G; Vandekerckhove B
J Immunol; 1999 Jan; 162(1):60-8. PubMed ID: 9886370
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
13. IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.
Ambrosini P; Loiacono F; Conte R; Moretta L; Vitale C; Mingari MC
Eur J Immunol; 2015 Jul; 45(7):2061-71. PubMed ID: 25847448
[TBL] [Abstract][Full Text] [Related]
14. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
[TBL] [Abstract][Full Text] [Related]
15. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
17. Notch increases T/NK potential of human hematopoietic progenitors and inhibits B cell differentiation at a pro-B stage.
Benne C; Lelievre JD; Balbo M; Henry A; Sakano S; Levy Y
Stem Cells; 2009 Jul; 27(7):1676-85. PubMed ID: 19544442
[TBL] [Abstract][Full Text] [Related]
18. Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development.
Schotte R; Dontje W; Nagasawa M; Yasuda Y; Bakker AQ; Spits H; Blom B
J Immunol; 2010 Jun; 184(12):6670-9. PubMed ID: 20483740
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
20. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
